Iovance Biotherapeutics, Inc. Stock Analysis
Technical stock analysis for 18 January 2019
Iovance Biotherapeutics, Inc. gained 0.64% in the last trading day, rising from $9.36 to $9.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a -1.15% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 87 057 more shares were traded than the day before. In total, 723 173 shares bought and sold for approximately $6.81 million.
Close price at the end of the last trading day (Friday, 18th Jan 2019) of the IOVA stock was $9.42. This is 0.64% more than the trading day before Thursday, 17th Jan 2019.
During day the stock fluctuated 2.69% from a day low at $9.29 to a day high of $9.54.
30 day high of the IOVA stock price was $10.30 and low was $7.26.
90 day high was $11.07 and low was $7.26.
52 week high for the Iovance Biotherapeutics, Inc. - $19.90 and low - $7.26.
Given the current horizontal trend you can expect Iovance Biotherapeutics, Inc. with 90% probability to be traded between $7.31 and $10.15 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Iovance Biotherapeutics, Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $9.35 and $9.27. A break down below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday January 15, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSI14 is 56 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $8.89 and $8.80.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iovance Biotherapeutics, Inc. finds support just below today's level at $8.89. If this is broken, then the next support from accumulated volume will be at $8.80 and $7.51.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.25 between high and low, or 2.69%. For the last week, the stock has had a daily average volatility of 4.91%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Iovance Biotherapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|IOVA $9.42 $0.06(0.64%)|
IOVA is up $0.06 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for IOVA based on the 1-3 month system that more than doubles the S&P 500.
Click here – the IOVA analysis is free »